Cooper Companies (COO) Stock Price, News & Analysis

Company Overview

Cooper Companies, Inc. (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories. Its portfolio includes single‐use, multifocal, toric and specialty lenses for presbyopia and astigmatism, supported by proprietary materials and manufacturing technologies. CooperSurgical focuses on women’s health and fertility solutions, offering products such as surgical instruments, diagnostic devices, and assisted reproductive technology tools designed for obstetrics, gynecology and fertility clinics.

With a presence in over 100 countries, CooperCompanies serves markets across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The company maintains manufacturing facilities and R&D centers in key regions, enabling close collaboration with healthcare professionals and customers to address evolving medical and patient needs.

CooperCompanies is guided by an experienced leadership team and board of directors committed to innovation, quality and compliance. Through ongoing investment in research and development, the company aims to expand its product offerings, enhance clinical outcomes and support the global healthcare community.

Key Stats

• Today's Range: $67.59 to $68.99
• 50-Day Range: $68.51 to $76.82
• 52-Week Range: $58.89 to $89.83
• Volume: 728,569 shs
• Average Volume: 2.30 million shs
• Market Capitalization: $13.29 billion
• P/E Ratio: 57.73
• Dividend Yield: N/A
• Price Target: $81.64
• Consensus Rating: Hold

Cooper Companies Stock Analysis - MarketRank™

Cooper Companies scored higher than 68% of companies evaluated by MarketBeat, and ranked 263rd out of 906 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Cooper Companies has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 1 strong buy rating, 7 buy ratings, 6 hold ratings, and 3 sell ratings.

Upside Potential

Cooper Companies has a consensus price target of $81.64, representing about 19.8% upside from its current price of $68.15.

Amount of Analyst Coverage

Cooper Companies has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.56%

Earnings Growth

Earnings for Cooper Companies are expected to grow by 7.56% in the coming year, from $4.63 to $4.98 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cooper Companies is 57.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.24.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cooper Companies is 57.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.80.

Price to Earnings Growth Ratio

Cooper Companies has a PEG Ratio of 1.82. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cooper Companies has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.00% of the float of Cooper Companies has been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 4.07.

Change versus previous month

Short interest in Cooper Companies has recently decreased by 8.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cooper Companies does not currently pay a dividend.

Dividend Growth

Cooper Companies does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.77

News Sentiment

Cooper Companies has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Cooper Companies this week, compared to 9 articles on an average week.

Search Interest

Only 5 people have searched for COO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

5 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cooper Companies insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.08% of the stock of Cooper Companies is held by insiders.

Percentage Held by Institutions

24.39% of the stock of Cooper Companies is held by institutions.

Company Calendar

• Last Earnings: 6/04/2026
• Today: 9/08/2026
• Next Earnings (Estimated): 9/09/2026
• Fiscal Year End: 10/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:COO
• Previous Symbol: NYSE:COO
• CIK: 711404
• Web: www.coopercos.com
• Phone: (925) 460-3600
• Fax: 925-460-3649
• Employees: 15,000
• Year Founded: 1958

Price Target and Rating

• Average Price Target for Cooper Companies: $81.64
• High Price Target: $103.00
• Low Price Target: $61.00
• Potential Upside/Downside: +19.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.35
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.18
• Trailing P/E Ratio: 57.73
• Forward P/E Ratio: 14.72
• P/E Growth: 1.82
• Net Income: $374.90 million
• Net Margins: 5.57%
• Pretax Margin: 9.75%
• Return on Equity: 10.88%
• Return on Assets: 7.27%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 1.27
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $4.09 billion
• Price / Sales: 3.25
• Cash Flow: $5.93 per share
• Price / Cash Flow: 11.49
• Book Value: $41.44 per share
• Price / Book: 1.64

Miscellaneous

• Outstanding Shares: 195,030,000
• Free Float: 190,974,000
• Market Cap: $13.29 billion
• Optionable: Optionable
• Beta: 0.82